Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Abnormal spindle-like microcephaly-associated protein (ASPM) is a large, conserved protein required for proper mitotic spindle function during cell division, particularly in neural progenitor cells[1][2][5]. It localizes to spindle poles and the midbody, with a key role in regulating spindle orientation, astral microtubule density, and ensuring balanced symmetric cell divisions[3][5]. In humans, loss-of-function mutations in the ASPM gene are the most common cause of autosomal recessive primary microcephaly, a disorder marked by reduced brain size with relatively intact architecture due to defective neurogenesis and proliferation[1][2][3]. ASPM’s function is also implicated in the proliferation of various tumors; high expression correlates with increased tumor growth and worse clinical outcomes in several CNS cancers[2][4]. While not a classical drug target (such as a kinase or receptor), ASPM's roles in cancer biology and developmental disease make it a putative target of therapeutic and research interest.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Abnormal spindle-like microcephaly-associated protein (ASPM).